Logo image of CROS.PA

CROSSWOOD (CROS.PA) Stock Fundamental Analysis

EPA:CROS - Euronext Paris - Matif - FR0000050395 - Common Stock - Currency: EUR

10.9  0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CROS. CROS was compared to 75 industry peers in the Real Estate Management & Development industry. CROS is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. CROS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

CROS had positive earnings in the past year.
In the past year CROS had a positive cash flow from operations.
Of the past 5 years CROS 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: CROS reported negative operating cash flow in multiple years.
CROS.PA Yearly Net Income VS EBIT VS OCF VS FCFCROS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M -4M 6M 8M

1.2 Ratios

With a decent Return On Assets value of 1.47%, CROS is doing good in the industry, outperforming 74.67% of the companies in the same industry.
CROS has a better Return On Equity (1.86%) than 68.00% of its industry peers.
CROS's Return On Invested Capital of 0.59% is in line compared to the rest of the industry. CROS outperforms 53.33% of its industry peers.
CROS had an Average Return On Invested Capital over the past 3 years of 0.44%. This is below the industry average of 4.54%.
The last Return On Invested Capital (0.59%) for CROS is above the 3 year average (0.44%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.47%
ROE 1.86%
ROIC 0.59%
ROA(3y)3.96%
ROA(5y)5.5%
ROE(3y)5.07%
ROE(5y)7.37%
ROIC(3y)0.44%
ROIC(5y)0.63%
CROS.PA Yearly ROA, ROE, ROICCROS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2 -2 4 6 8 10

1.3 Margins

Looking at the Profit Margin, with a value of 150.55%, CROS belongs to the top of the industry, outperforming 97.33% of the companies in the same industry.
CROS has a better Operating Margin (86.10%) than 98.67% of its industry peers.
In the last couple of years the Operating Margin of CROS has declined.
CROS's Gross Margin of 81.23% is amongst the best of the industry. CROS outperforms 81.33% of its industry peers.
CROS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 86.1%
PM (TTM) 150.55%
GM 81.23%
OM growth 3Y-0.97%
OM growth 5Y-16.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.32%
GM growth 5Y3.08%
CROS.PA Yearly Profit, Operating, Gross MarginsCROS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 400 600

More info and screens

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CROS is destroying value.
The number of shares outstanding for CROS remains at a similar level compared to 1 year ago.
CROS has about the same amout of shares outstanding than it did 5 years ago.
CROS has a better debt/assets ratio than last year.
CROS.PA Yearly Shares OutstandingCROS.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
CROS.PA Yearly Total Debt VS Total AssetsCROS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

CROS has an Altman-Z score of 4.24. This indicates that CROS is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 4.24, CROS belongs to the best of the industry, outperforming 98.67% of the companies in the same industry.
CROS has a debt to FCF ratio of 2.27. This is a good value and a sign of high solvency as CROS would need 2.27 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 2.27, CROS belongs to the best of the industry, outperforming 98.67% of the companies in the same industry.
A Debt/Equity ratio of 0.04 indicates that CROS is not too dependend on debt financing.
The Debt to Equity ratio of CROS (0.04) is better than 86.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 2.27
Altman-Z 4.24
ROIC/WACC0.08
WACC7.7%
CROS.PA Yearly LT Debt VS Equity VS FCFCROS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 1.28 indicates that CROS should not have too much problems paying its short term obligations.
CROS has a Current ratio (1.28) which is comparable to the rest of the industry.
CROS has a Quick Ratio of 1.28. This is a normal value and indicates that CROS is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.28, CROS is doing good in the industry, outperforming 78.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 1.28
CROS.PA Yearly Current Assets VS Current LiabilitesCROS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

CROS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 226.76%, which is quite impressive.
Looking at the last year, CROS shows a decrease in Revenue. The Revenue has decreased by -6.15% in the last year.
Measured over the past years, CROS shows a decrease in Revenue. The Revenue has been decreasing by -2.96% on average per year.
EPS 1Y (TTM)226.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%289.84%
Revenue 1Y (TTM)-6.15%
Revenue growth 3Y-12.91%
Revenue growth 5Y-2.96%
Sales Q2Q%0.54%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CROS.PA Yearly Revenue VS EstimatesCROS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M
CROS.PA Yearly EPS VS EstimatesCROS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 77.86, which means the current valuation is very expensive for CROS.
62.67% of the companies in the same industry are more expensive than CROS, based on the Price/Earnings ratio.
CROS is valuated expensively when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 77.86
Fwd PE N/A
CROS.PA Price Earnings VS Forward Price EarningsCROS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, CROS is valued a bit cheaper than the industry average as 62.67% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 62.56
EV/EBITDA N/A
CROS.PA Per share dataCROS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The decent profitability rating of CROS may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

2

5. Dividend

5.1 Amount

CROS has a yearly dividend return of 0.92%, which is pretty low.
CROS's Dividend Yield is comparable with the industry average which is at 7.15.
Compared to an average S&P500 Dividend Yield of 2.33, CROS's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.92%

5.2 History

On average, the dividend of CROS grows each year by 125.18%, which is quite nice.
Dividend Growth(5Y)125.18%
Div Incr Years1
Div Non Decr Years1
CROS.PA Yearly Dividends per shareCROS.PA Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 0.1 0.2 0.3

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
CROS.PA Yearly Income VS Free CF VS DividendCROS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M -4M 6M 8M

More info and screens

CROSSWOOD

EPA:CROS (3/6/2025, 7:00:00 PM)

10.9

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners95.04%
Ins Owner ChangeN/A
Market Cap115.87M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.92%
Yearly Dividend0.11
Dividend Growth(5Y)125.18%
DP0%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 77.86
Fwd PE N/A
P/S 115.06
P/FCF 62.56
P/OCF 45.08
P/B 1.42
P/tB 1.42
EV/EBITDA N/A
EPS(TTM)0.14
EY1.28%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.17
FCFY1.6%
OCF(TTM)0.24
OCFY2.22%
SpS0.09
BVpS7.66
TBVpS7.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.47%
ROE 1.86%
ROCE 0.86%
ROIC 0.59%
ROICexc 0.6%
ROICexgc 0.6%
OM 86.1%
PM (TTM) 150.55%
GM 81.23%
FCFM 183.91%
ROA(3y)3.96%
ROA(5y)5.5%
ROE(3y)5.07%
ROE(5y)7.37%
ROIC(3y)0.44%
ROIC(5y)0.63%
ROICexc(3y)0.45%
ROICexc(5y)0.65%
ROICexgc(3y)0.45%
ROICexgc(5y)0.65%
ROCE(3y)0.65%
ROCE(5y)0.93%
ROICexcg growth 3Y-15.8%
ROICexcg growth 5Y-23.21%
ROICexc growth 3Y-15.79%
ROICexc growth 5Y-23.21%
OM growth 3Y-0.97%
OM growth 5Y-16.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.32%
GM growth 5Y3.08%
F-Score7
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 2.27
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 13.55
Cash Conversion N/A
Profit Quality 122.16%
Current Ratio 1.28
Quick Ratio 1.28
Altman-Z 4.24
F-Score7
WACC7.7%
ROIC/WACC0.08
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)41.17%
Cap/Sales(5y)29.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)226.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%289.84%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.15%
Revenue growth 3Y-12.91%
Revenue growth 5Y-2.96%
Sales Q2Q%0.54%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y144.23%
EBIT growth 3Y-13.76%
EBIT growth 5Y-18.9%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y240.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y549.3%
OCF growth 3Y-22.79%
OCF growth 5Y-21.99%